Encyclopedia of Toxicology 2024
DOI: 10.1016/b978-0-12-824315-2.01134-9
|View full text |Cite
|
Sign up to set email alerts
|

Anti diabetic agents

Sidhartha D. Ray,
Azhar Hussain,
Aniqa Niha
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 25 publications
0
1
0
Order By: Relevance
“…[6][7][8] a-Glucosidase inhibitors are used to treat type 2 diabetes by slowing the absorption of carbohydrates in the small intestine. 9 These inhibitors have multiple advantages in controlling diabetes, including delayed digestion of complex carbohydrates, slowing glucose release, reducing postprandial hyperglycemia, and regulating postprandial glucose levels. 3,6 Typically used alongside other anti-diabetic medications or insulin therapy, aglucosidase inhibitors can enhance a diabetes management plan and are rarely used as initial treatments (Fig.…”
Section: Introductionmentioning
confidence: 99%
“…[6][7][8] a-Glucosidase inhibitors are used to treat type 2 diabetes by slowing the absorption of carbohydrates in the small intestine. 9 These inhibitors have multiple advantages in controlling diabetes, including delayed digestion of complex carbohydrates, slowing glucose release, reducing postprandial hyperglycemia, and regulating postprandial glucose levels. 3,6 Typically used alongside other anti-diabetic medications or insulin therapy, aglucosidase inhibitors can enhance a diabetes management plan and are rarely used as initial treatments (Fig.…”
Section: Introductionmentioning
confidence: 99%